Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- EOXPIndependent statistical analysis of Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EPAD Monitoring of Patients Undergoing Robotic Assisted Laparoscopic Genitourinary Surgery: Complete Statistical AnalysisIndependent statistical analysis of EPAD Monitoring of Patients Undergoing Robotic Assisted Laparoscopic Genitourinary Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03319407).
- EPALDIndependent statistical analysis of Effect of Probiotics on Gut-Liver Axis of Alcoholic Liver Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01501162).
- EPAT: Phase IIIndependent statistical analysis of Early Propranolol After Traumatic Brain Injury: Phase II: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01202110).
- EPERCIndependent statistical analysis of Early Percutaneous Cryoablation for Pain Control After Rib Fractures Among Elderly Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- EpHectIndependent statistical analysis of Clinical Performance of the Gedea Pessary in Adult Women With Vulvovaginal Candidiasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ePHex-OLEIndependent statistical analysis of An Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- EPHFCDCCIndependent statistical analysis of Effect of pH and Fluoride Concentration of Dentifrices on Caries Control: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EPI VITRAKVIIndependent statistical analysis of A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type of Connective Soft Tissue Cancer, Who Received a Treatment Called Larotrectinib…
- EPI-743 for Metabolism or Mitochondrial Disorders: Complete Statistical AnalysisIndependent statistical analysis of EPI-743 for Metabolism or Mitochondrial Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01642056).
- EPICIndependent statistical analysis of Mechanisms of EPO-induced Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03810911).
- EPICIndependent statistical analysis of Early Parenting Intervention Comparison: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01517867).
- EPICIndependent statistical analysis of Engaging Patients With Mental Disorders From the ED in Outpatient Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EPIC-HFIndependent statistical analysis of Electronic Health Record-leveraged, Patient-centered, Intensification of Chronic Care for HF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03334188).
- EPIC-SRIndependent statistical analysis of EPIC-SR (NCT05011513), the randomized, placebo-controlled phase 2/3 trial of nirmatrelvir plus ritonavir in standard-risk COVID-19, covering the log-rank primary analysis, logistic-regression odds ratios, negative binomial modelling and serious…
- EPICAIndependent statistical analysis of Study of Efficacy and Safety of MEXIDOL® in Ischemic Stroke Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EpiCeram for Skin Protection in Healthcare Workers: Complete Statistical AnalysisIndependent statistical analysis of EpiCeram for Skin Protection in Healthcare Workers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04793711).
- EPICSIndependent statistical analysis of Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Epidemiological Study of the COVID-2019 in Participating Organizations.: Complete Statistical AnalysisIndependent statistical analysis of Epidemiological Study of the COVID-2019 in Participating Organizations.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05043142).
- Epidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the Community: Complete Statistical AnalysisIndependent statistical analysis of Epidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the Community: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Epidemiology of Acute Kidney Injury in England – 1998 to 2013: Complete Statistical AnalysisIndependent statistical analysis of Epidemiology of Acute Kidney Injury in England - 1998 to 2013: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Epidemiology of Depression, Anxiety, and Cognitive Impairment: Complete Statistical AnalysisIndependent statistical analysis of Epidemiology of Depression, Anxiety, and Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00717041).
- Epiduo Pediatric Acne Study: Complete Statistical AnalysisIndependent statistical analysis of Epiduo Pediatric Acne Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01138735).
- Epidural Neostigmine for Labor Pain: Complete Statistical AnalysisIndependent statistical analysis of Epidural Neostigmine for Labor Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00779467).
- Epidural Neuroplasty for the Treatment of Herniated Lumbar Disk: Complete Statistical AnalysisIndependent statistical analysis of Epidural Neuroplasty for the Treatment of Herniated Lumbar Disk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03101033).
- Epigenetic Regulation of BDNF in Major Depression: Complete Statistical AnalysisIndependent statistical analysis of Epigenetic Regulation of BDNF in Major Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01182103).
- EPIGRAAFTIndependent statistical analysis of Epidermal Grafting in Wound Healing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02535481).
- Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Epitome2extIndependent statistical analysis of Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01470144).
- EPMCS-CAIndependent statistical analysis of A Prospective, Multi-Center Evaluation of the ECHELON CIRCULAR Powered Stapler in Left-Sided Colorectal Anastomoses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- EPOIndependent statistical analysis of Treating Patients With Aneurysmal SubArachnoid Hemorrhage (SAH) With Epoetin Alfa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00626574).
- EPOCHIndependent statistical analysis of An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- EPOCH-RRTIndependent statistical analysis of Empowering Patients On Choices for Renal Replacement Therapy (Aim 3) (EPOCH-RRT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer: Complete Statistical AnalysisIndependent statistical analysis of Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ePrEPIndependent statistical analysis of Electronic Pre-exposure Prophylaxis (PrEP) Initiation and Maintenance Home Care System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03729570).
- EPT and MSMIndependent statistical analysis of Expedited Partner Therapy and the HIV Prevention Cascade: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04553211).
- EQUATEIndependent statistical analysis of A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- EQUATORIndependent statistical analysis of Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- EQUIPIndependent statistical analysis of A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- EQUIP-2Independent statistical analysis of Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00137280).
- EQUIPED-ADRDIndependent statistical analysis of Enhanced Quality in Primary Care for Elders With Diabetes and Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EQUIPPEDIndependent statistical analysis of Efficiency And Quality In Post-Surgical Pain Therapy After Discharge: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05221866).
- EQUIPPEDIndependent statistical analysis of Reducing Potentially Inappropriate Medication Prescribing for Older Patients in the ED: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EQUIPSIndependent statistical analysis of Enhancing Quality Interventions Promoting Healthy Sexuality: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01818791).
- Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon: Complete Statistical AnalysisIndependent statistical analysis of Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ERA-PAHIndependent statistical analysis of Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02911844).
- eRADicAteIndependent statistical analysis of Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis:…
- ERADICATE HpIndependent statistical analysis of ERADICATE Hp - Treating Helicobacter Pylori With RHB-105: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01980095).
- ERASE-MIIndependent statistical analysis of Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…